GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Healios KK (TSE:4593) » Definitions » Enterprise Value

Healios KK (TSE:4593) Enterprise Value : 円13,518.5 Mil (As of Dec. 14, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Healios KK Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Healios KK's Enterprise Value is 円13,518.5 Mil. Healios KK's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was 円-2,536.0 Mil. Therefore, Healios KK's EV-to-EBIT ratio for today is -5.33.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Healios KK's Enterprise Value is 円13,518.5 Mil. Healios KK's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was 円-2,314.0 Mil. Therefore, Healios KK's EV-to-EBITDA ratio for today is -5.84.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Healios KK's Enterprise Value is 円13,518.5 Mil. Healios KK's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was 円522.0 Mil. Therefore, Healios KK's EV-to-Revenue ratio for today is 25.90.


Healios KK Enterprise Value Historical Data

The historical data trend for Healios KK's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healios KK Enterprise Value Chart

Healios KK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68,497.26 99,114.42 67,590.37 16,760.65 10,121.64

Healios KK Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17,579.24 15,197.76 10,121.64 10,297.41 14,350.70

Competitive Comparison of Healios KK's Enterprise Value

For the Biotechnology subindustry, Healios KK's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healios KK's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Healios KK's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Healios KK's Enterprise Value falls into.



Healios KK Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Healios KK's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Healios KK's Enterprise Value for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Healios KK  (TSE:4593) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Healios KK's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=13518.530/-2536
=-5.33

Healios KK's current Enterprise Value is 円13,518.5 Mil.
Healios KK's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-2,536.0 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Healios KK's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=13518.530/-2314
=-5.84

Healios KK's current Enterprise Value is 円13,518.5 Mil.
Healios KK's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-2,314.0 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Healios KK's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=13518.530/522
=25.90

Healios KK's current Enterprise Value is 円13,518.5 Mil.
Healios KK's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円522.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Healios KK Enterprise Value Related Terms

Thank you for viewing the detailed overview of Healios KK's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Healios KK Business Description

Traded in Other Exchanges
Address
World Trade Center Bldg. 15th Floor, 2-4-1 Hamamatsucho, Minato-ku, Tokyo, JPN, 105-6115
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy.

Healios KK Headlines

No Headlines